Companies and Research Institutes mentioned / covered in this report:
Commerical entities developing iPSC therapies: ViaCyte, Fate Therapeutic, iPerian, Cellular Dynamics and Mesoblast.
Strategic collaborations for development of iPSC products: Life Technologies, Lonza Group AG, EMD Millipore, Sigma Aldrich, Roslin Cells, Ltd., ArunA Biomedical, CeeTox and Cellular Dynamics.
Top research institutions performing stem cell research: University of Wisconsin, including WARF, WiCell, and the WISC Bank, US National Institutes of Health (NIH), Johns Hopkins University, California Institute for Regenerative Medicine and University of Connecticut Induced Pluripotent Stem Cell Core (iPSCC).
Comprehensive Table of Contents and more on the report Complete 2012-13 Induced Pluripotent Stem Cell Industry Report on Market Metrics, Dynamics, and Trends @ http://www.reportsnreports.com/reports/206575-complete-2012-13-induced-pluripotent-stem-cell-industry-report.html.
Special Offers on Other Relevant Reports Valid Till June 30, 2013:
Mesenchymal Stem Cells - Advances & Applications – 15% OFF if ordered by June 30, 2013.
Complete 2012-13 U.S. Cord Blood Banking Industry Report – 15% OFF if ordered by June 30, 2013
ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. We provide 24/7 online and offline support service to our customers.
Copyright©2012 Vocus, Inc.
All rights reserved